[Federal Register: June 26, 2009 (Volume 74, Number 122)]
[Notices]               
[Page 30620-30621]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr26jn09-132]                         

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Importer of Controlled Substances; Notice of Application

    Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this 
is notice that on May 8, 2009, Chattem Chemicals, Inc., 3801 St. Elmo 
Avenue, Building 18, Chattanooga, Tennessee 37409, made application by 
renewal to the Drug Enforcement Administration (DEA) for registration 
as an importer of the basic classes of controlled substances listed in 
schedule II:


------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Methamphetamine (1105).....................  II
Phenylacetone (8501).......................  II
Raw Opium (9600)...........................  II
Concentrate of Poppy Straw (9670)..........  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances to 
manufacture bulk controlled substances for sale to its customers.
    No comments, objections, or requests for any hearings will be 
accepted on any application for registration or re-registration to 
import crude opium, poppy straw, concentrate of poppy straw, and coca 
leaves. As explained in the Correction to Notice of Application 
pertaining to Rhodes Technologies, 72 FR 3417 (2007), comments and 
requests for hearings on applications to import narcotic raw material 
are not appropriate.
    Any bulk manufacturer who is presently, or is applying to be, 
registered with DEA to manufacture such basic classes of controlled 
substances listed in schedule I or II, which fall under the authority 
of section 1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may, in 
the circumstances set forth in 21 U.S.C. 958(i), file comments or 
objections to the issuance of the proposed registration and may, at the 
same time, file a written request for a hearing on such application 
pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 
1316.47.
    Any such comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than July 27, 2009.
    This procedure is to be conducted simultaneously with, and 
independent of, the procedures described in 21 CFR

[[Page 30621]]

1301.34(b), (c), (d), (e), and (f). As noted in a previous notice 
published in the Federal Register on September 23, 1975, (40 FR 43745-
46), all applicants for registration to import a basic class of any 
controlled substances in schedule I or II are, and will continue to be, 
required to demonstrate to the Deputy Assistant Administrator, Office 
of Diversion Control, Drug Enforcement Administration, that the 
requirements for such registration pursuant to 21 U.S.C. 958(a), 21 
U.S.C. 823(a), and 21 CFR Sec.  1301.34(b), (c), (d), (e), and (f) are 
satisfied.

    Dated: June 22, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-15228 Filed 6-25-09; 8:45 am]

BILLING CODE 4410-09-M